Published in Curr Med Res Opin on January 01, 2003
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int (2009) 1.14
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag (2010) 1.12
Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int (2008) 1.02
A reappraisal of generic bisphosphonates in osteoporosis. Osteoporos Int (2011) 0.98
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disord (2010) 0.90
Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture. PLoS One (2013) 0.83
Bisphosphonates for the treatment of osteoporosis: insights for clinicians. Ther Adv Chronic Dis (2010) 0.82
Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database. Clinicoecon Outcomes Res (2013) 0.80
Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis. Osteoporos Int (2007) 0.79
Comment on Disintegration/dissolution profiles of copies of Fosamax (alendronate). Curr Med Res Opin (2004) 0.76
Upper gastrointestinal tract transit times of tablet and drinkable solution formulations of alendronate: a bioequivalence and a quantitative, randomized study using video deglutition. Calcif Tissue Int (2012) 0.75
Pharmaceutical Evaluation of Cefuroxime Axetil Tablets Available in Drug Market of Pakistan. Indian J Pharm Sci (2016) 0.75
Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates. J Osteoporos (2014) 0.75
A critical review of brand and generic alendronate for the treatment of osteoporosis. Springerplus (2013) 0.75
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 6.62
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94
Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology (1998) 4.01
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90
Ondansetron for prevention of postoperative nausea and vomiting following minor oral surgery: a double-blind randomized study. Anaesth Intensive Care (1994) 2.59
A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
Community level factors and child maltreatment rates. Child Dev (1995) 2.23
Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol (1993) 2.17
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol (1996) 1.92
Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86
Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82
HHV-6 in AIDS. Lancet (1994) 1.76
Single-turnover and pre-steady-state kinetics of the reaction of the adenine glycosylase MutY with mismatch-containing DNA substrates. Biochemistry (1998) 1.75
Infrared signature of structures associated with the H+(H2O)n (n = 6 to 27) clusters. Science (2004) 1.71
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
Biochemistry of Oleoresinosis : Monoterpene and Diterpene Biosynthesis in Lodgepole Pine Saplings Infected with Ceratocystis clavigera or Treated with Carbohydrate Elicitors. Plant Physiol (1987) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis (1998) 1.67
Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol (1979) 1.66
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS (1999) 1.65
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS (1996) 1.64
Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Med (1994) 1.64
Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. Int J Cancer (2001) 1.62
Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol (1981) 1.61
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax (2006) 1.60
Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta (1994) 1.59
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Biosynthesis of monoterpenes: partial purification, characterization, and mechanism of action of 1,8-cineole synthase. Arch Biochem Biophys (1994) 1.53
Data on fibre size in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 1.53
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res (2000) 1.51
Early diagnosis of HIV infection. Br J Hosp Med (1990) 1.51
Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int (2005) 1.51
Age-related hearing loss, vitamin B-12, and folate in elderly women. Am J Clin Nutr (1999) 1.49
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48
Follow up studies: design, organisation, and analysis. Arch Dis Child (1989) 1.47
Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol (1994) 1.47
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002. HIV Med (2004) 1.44
Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat? Clin Infect Dis (2003) 1.44
HIV and other sexually transmitted infections among men, transgenders and women selling sex in two cities in Pakistan: a cross-sectional prevalence survey. Sex Transm Infect (2009) 1.43
Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain (1995) 1.42
Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone (1996) 1.42
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum (1992) 1.42
The effect of glutathione on development in wild carrot suspension cultures. Biochem Biophys Res Commun (1985) 1.42
The Georgia Centenarian Study. Int J Aging Hum Dev (1992) 1.41
Paradoxical vocal cord motion: an unusual cause of stridor in the recovery room. Anesthesiology (1993) 1.41
Effects of physical activity and age on mitochondrial function. QJM (1996) 1.39
Visual abnormalities associated with high-energy microwave exposure. Retina (1993) 1.38
[Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment]. Medicina (B Aires) (1992) 1.38
Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology (1999) 1.37
The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol (1993) 1.37
Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet (1997) 1.34
A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci (1983) 1.34
Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol Aging (2001) 1.33
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res (2001) 1.29
Retinal sensitivity over drusen and nondrusen areas. A study using fundus perimetry. Arch Ophthalmol (1988) 1.28
Immediate provisional for single-tooth implant replacement with Brånemark system: preliminary report. Clin Implant Dent Relat Res (2001) 1.27
Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology (1996) 1.27
Reduced bone mineral density in HIV-positive individuals. AIDS (2001) 1.26
BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. HIV Med (2005) 1.26
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine. AIDS (1999) 1.26
Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci (2001) 1.25
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest (1996) 1.24
Morphology and physiology of skeletal muscle in aging rodents. Muscle Nerve (1980) 1.24
Lipodystrophy in patients naive to HIV protease inhibitors. AIDS (1999) 1.23
Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. J Acquir Immune Defic Syndr (1999) 1.23
New molecular phenotypes in the dst mutants of Arabidopsis revealed by DNA microarray analysis. Plant Cell (2001) 1.23
Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med (2002) 1.22
Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol (1996) 1.22
Psoralen-DNA photoreaction: controlled production of mono- and diadducts with nanosecond ultraviolet laser pulses. Science (1977) 1.22
Social and psychological resources in the oldest old. Exp Aging Res (1996) 1.21
Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis. Antimicrob Agents Chemother (1987) 1.19
Peripheral absolute threshold spectral sensitivity in retinitis pigmentosa. Br J Ophthalmol (1981) 1.19
Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS (1995) 1.18